Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BEAM | Beam Therapeutics Inc. | Chief Financial Officer | $3.13M | -$175K | -5.29% | Apr 26, 2024 |
RXRX | RECURSION PHARMACEUTICALS, INC. | Director | $514K | Jul 1, 2024 | ||
RAPP | Rapport Therapeutics, Inc. | Director | Jun 6, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|